Drug profile · INN
abacavir, dolutegravir, lamivudine
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
abacavir, dolutegravir, lamivudine (ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is abacavir, dolutegravir, lamivudine?
abacavir, dolutegravir, lamivudine (ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for abacavir, dolutegravir, lamivudine?
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE is a marketed brand name for abacavir, dolutegravir, lamivudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of abacavir, dolutegravir, lamivudine?
abacavir, dolutegravir, lamivudine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.